These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24614354)

  • 1. Argatroban as novel therapy for suspected thrombosis in patients with continuous-flow left ventricle assist device and hemolysis.
    Badiye A; Hernandez GA; Chaparro S
    ASAIO J; 2014; 60(3):361-5. PubMed ID: 24614354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices.
    Bitar A; Vijayakrishnan R; Lenneman A; Birks E; Massey T; Slaughter M; Abramov D
    Artif Organs; 2017 Dec; 41(12):1092-1098. PubMed ID: 28621461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalirudin for treatment of LVAD thrombosis: a case series.
    Sylvia LM; Ordway L; Pham DT; DeNofrio D; Kiernan M
    ASAIO J; 2014; 60(6):744-7. PubMed ID: 25072553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
    Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
    J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death.
    Levin AP; Saeed O; Willey JZ; Levin CJ; Fried JA; Patel SR; Sims DB; Nguyen JD; Shin JJ; Topkara VK; Colombo PC; Goldstein DJ; Naka Y; Takayama H; Uriel N; Jorde UP
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis.
    Fine NM; Topilsky Y; Oh JK; Hasin T; Kushwaha SS; Daly RC; Joyce LD; Stulak JM; Pereira NL; Boilson BA; Clavell AL; Edwards BS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1129-40. PubMed ID: 24094831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, Management, and Outcome of Suspected Continuous-Flow Left Ventricular Assist Device Thrombosis.
    Upshaw JN; Kiernan MS; Morine KJ; Kapur NK; DeNofrio D
    ASAIO J; 2016; 62(1):33-9. PubMed ID: 26479464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombosis in continuous-flow left ventricular assist devices: pathophysiology, prevention, and pharmacologic management.
    Jennings DL; Weeks PA
    Pharmacotherapy; 2015 Jan; 35(1):79-98. PubMed ID: 25329333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device.
    Muthiah K; Robson D; Macdonald PS; Keogh AM; Kotlyar E; Granger E; Dhital K; Spratt P; Jansz P; Hayward CS
    Artif Organs; 2013 Mar; 37(3):313-8. PubMed ID: 23373528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon.
    Uriel N; Han J; Morrison KA; Nahumi N; Yuzefpolskaya M; Garan AR; Duong J; Colombo PC; Takayama H; Thomas S; Naka Y; Jorde UP
    J Heart Lung Transplant; 2014 Jan; 33(1):51-9. PubMed ID: 24290832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
    Cowger JA; Romano MA; Shah P; Shah N; Mehta V; Haft JW; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bivalirudin Experience in a Heterogeneous Ventricular Assist Device Population.
    Bates A; Buchholz H; Freed D; MacArthur R; PiDBorochynski T; Conway J
    ASAIO J; 2020 Jun; 66(6):677-682. PubMed ID: 31567418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolysis in left ventricular assist device: a retrospective analysis of outcomes.
    Ravichandran AK; Parker J; Novak E; Joseph SM; Schilling JD; Ewald GA; Silvestry S
    J Heart Lung Transplant; 2014 Jan; 33(1):44-50. PubMed ID: 24418733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
    Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L
    Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline for the treatment of hemolytic anemia in a patient who developed recurrent gastrointestinal bleeding while on continuous-flow left ventricular assist device support.
    Jennings DL; Williams CT; Morgan JA
    ASAIO J; 2013; 59(5):526-7. PubMed ID: 23896772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
    Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
    J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous-flow left ventricular assist device exchange: clinical outcomes.
    Ota T; Yerebakan H; Akashi H; Takayama H; Uriel N; Colombo PC; Jorde UP; Naka Y
    J Heart Lung Transplant; 2014 Jan; 33(1):65-70. PubMed ID: 23937885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: a Japanese multicenter study using J-MACS.
    Saito S; Yamazaki K; Nishinaka T; Ichihara Y; Ono M; Kyo S; Nishimura T; Nakatani T; Toda K; Sawa Y; Tominaga R; Tanoue T; Saiki Y; Matsui Y; Takemura T; Niinami H; Matsumiya G;
    J Heart Lung Transplant; 2014 Jun; 33(6):599-608. PubMed ID: 24746637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.